Aa
ARWR today's data presentation
Arrowhead presents data showing that in chronically HBV-infected chimpanzees treated with ARC-520 in combination with nucleoside analogs, 78% exhibited signs of immune reactive.
Will see 2020 is not that far. But every one seems optimistic with their latest data.
I hope im wrong but I believe arrow head are chasing a dead end with arc520
From the global 400million chronic ppl is there any status that indicates Hbeag postive or Hbeag negative higher in number? My thought is Hbeag negative.
which is likely a necessary step for achieving a functional cure of chronic HBV
One chimpanzee also exhibited an on-treatment therapeutic ALT flare and sustained virologic improvements 31 weeks off all treatment. ARC-520 is currently being studied in multiple Phase 2b global clinical trials
One chimpanzee also exhibited an on-treatment therapeutic ALT flare and sustained virologic improvements 31 weeks off all treatment. ARC-520 is currently being studied in multiple Phase 2b global clinical trials
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
